Epi Soul logo image Epi Soul logo image
  1. UW Home |
  2. SPH  |
  3. Other Departments |
online giving

Andy S. Stergachis, PhD, MS, BPharm

Associate Dean, School of Pharmacy
Professor, Pharmacy
Professor, Global Health
Adjunct Professor, Epidemiology
Adjunct Professor, Health Services

Contact Information
Director, Global Medicines Program
Harris Hydraulics Building, Room 321
Seattle, WA 98105
Tel: 206-543-3421
Fax: 206-685-0703

Northwest Center for Public Health Practice

Research Interests
Dr. Stergachis' research focus is pharmacoepidemiology, global medicines safety, pharmaceutical outcomes research, and public health systems research. He is currently PI of the University of Washington components of two pharmacovigilance projects funded by the Bill & Melinda Gates Foundation, including multi-center global clinical trials program of alternative antimalarial case management and prevention strategies in pregnancy. He is the PI of the UW component of a USAID-funded cooperative agreement with Management Sciences for Health on Strengthening Pharmaceutical Systems in developing countries. Through his affiliation with the Northwest Center for Public Health Practice, he also works on workforce development and research in emergency preparedness with the public health community. He is also affiliated with the Pharmaceutical Outcomes Research and Policy program. He has served on Institute of Medicine's Committees, including the Committee on Poison Prevention and Control System, and the Committee on Assessment of the U.S. Drug Safety System. His international responsibilities includes the Advisory Group to Global Alert and Response for the World Health Organization. Locally, he is a member of the Public Health Reserve Corps.

Teaching Interests
Pharmacoepidemiology, global medicines safety and pharmacovigilance, and public health systems research.

PhD, Pharmacy, University of Minnesota 1979
MS, Pharmacy, University of Minnesota 1976
BPharm, Pharmacy, Washington State University 1975

Assessment of the Safety of Antimalarial Drug Use During Early Pregnancy Malaria in Pregnancy Consortium & BMGF

Systems for Improving Access to Pharmaceuticals and Services (SIAPS) with Management Sciences for Health USAID

Selected Publications
Stergachis A, Wetmore CM, Pennylegion M, Beaton RD, Karras BT, Webb D, Young D, Loehr M. Evaluation of a Mass Dispensing Functional Exercise in a Cities Readiness Initiative Setting. Am J Health-Systems Pharmacy. 2007;64:285-93.

Schech S, Graham D, Staffa J, Andrade SE, Grenade LL, Burgess M, Blough D, Stergachis A, Chan KA, Platt R, Shatin D. Risk Factors for Statin-Associated Rhabdomyolysis. Pharmacoepidemiol Drug Saf. 2007;16:352-8.

Olsen S, Pal S, Stergachis A, Couper M. An analysis of pharmacovigilance activities in 55 low- and middle income countries. Drug Safety. 2010;33:689-703.

Stergachis A, Bartlein R, Dodoo A, Nwokike J, Kachur SP. A situational analysis of pharmacovigilance plans in the Global Fund Malaria and U.S Presidents' Malaria Initiative proposals. Malaria J. 2010: 9:148.

Paige S, Jones M, D'Ambrosio L, Taylor W, Bonnie D, Loehr M, Stergachis A. Building community partnerships through a pandemic influenza exercise series in King County, WA. Public Health Reports. 2010;125:488-93.

Dellicour S, ter Kuile F, Stergachis A. Pregnancy Exposure Registries for Assessing Antimalarial Drug Safety in Pregnancy in Malaria Endemic Countries. PLoS Medicine. Vol. 5, No. 9, e187 doi:10.1371/journal.pmed.0050187


In the news
Three School of Public Health faculty members elected to Institute of Medicine (UW News)

Last Reviewed on 1/18/2012

FacBio XML parser code Epi